Early drug development requires adherence to Good Manufacturing Practices (GMP) guidelines when manufacturing investigational medicinal products (IMPs) for clinical studies conducted within Europe. Studies which are directly supported by GMP-compliant on-site manufacturing facilities add substantial value by significantly cutting costs and timelines through proven, efficiency-focused processes.
Bioanalysis, Biomarker and Flow Cytometry Assay List
Bioanalysis, Biomarker and Flow Cytometry Assay List. PRA Laboratories—Solutions for Drug Development. Behind every sample waiting to be analyzed,…
Salt Lake City Research Unit
Video highlighting Salt Lake City Resarch Unit, and its capabilities
Pharmacogenomics in Pain Management
Pharmacogenomics in Pain Management. In the US alone there are an estimated 100 million adults suffering from chronic pain. Pharmacogenomics and…